SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Repligen Corp (RGEN) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (149)9/7/1999 1:00:00 PM
From: Curtis E. Bemis  Read Replies (1) | Respond to of 395
 
Hi-- Their Annual Report has a lot of info-

Yes, like all small struggling BioTechs, cash is always of
concern. They do have the Protein-A cash cow and that keeps
things flush. I think they have the savvy to pull off the
Secretin thing, thru the trials and all that, and the CTLA4
has great promise and they appear to have trimmed unecessary
diversions to focus on the most promising aspects.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News